BioPharmSignal logoBioPharmSignal

Biotech News

Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutions

Materialise (MTLS)MaterialiseCompany update

LEUVEN, Belgium, July 01, 2026 (GLOBE NEWSWIRE) -- MATERIALISE NV Technologielaan 15 3001 Leuven Company number: 0441.131.254 RPR Leuven (the " Company ") Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutions Free

Related news

MTLSMaterialise2026-05-15 20:01 EST

Materialise to Hold Annual Shareholders’ Meeting on June 16, 2026

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

View all latest news

Materialise

Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models. Medical Solutions The medical segment develops patient-specific surgical planning tools, anatomical...

Recent company news

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-07-13 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-07-13 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-07-06 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

Stock data

Close
6.75 USD
Market cap
401.4M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States